Qube Research & Technologies (QRT)
DXCM icon

Qube Research & Technologies (QRT)’s DexCom DXCM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Sell
50,100
-73,600
-59% -$5.13M ﹤0.01% 1915
2025
Q4 		$8.21M Buy
123,700
+5,100
+4% +$330K 0.01% 1470
2025
Q3 		$7.98M Sell
118,600
-19,900
-14% -$1.57M 0.01% 1456
2025
Q2 		$12.1M Sell
138,500
-75,300
-35% -$5.9M 0.01% 1175
2025
Q1 		$14.6M Buy
213,800
+28,700
+16% +$2.34M 0.02% 908
2024
Q4 		$14.4M Buy
185,100
+116,800
+171% +$8.65M 0.02% 878
2024
Q3 		$4.58M Buy
68,300
+65,100
+2,034% +$5.35M 0.01% 1436
2024
Q2 		$363K Buy
+3,200
New +$405K ﹤0.01% 2242
2023
Q4 		– Sell
-1,800
Closed -$168K – 4435
2023
Q3 		$168K Buy
+1,800
New +$203K ﹤0.01% 2459

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DXCM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of DexCom (DXCM) in Q1 2026, closing a stake of 151,947 shares — an estimated $10.6M sold.

Qube Research & Technologies (QRT) first reported a position in DXCM in Q2 2020 and held it in 16 quarters. The position peaked at $142M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 151,947 DexCom shares in Q1 2026, an estimated $10.6M.
  • Qube Research & Technologies (QRT) first reported a position in DexCom in Q2 2020 and held it in 16 quarters.
  • Qube Research & Technologies (QRT)'s DexCom position peaked at $142M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.